Argenx CEO Steps Down: Tim Van Hauwermeiren Transitions to Chairman as Karen Massey Takes the Helm
Belgian-Dutch biotech powerhouse argenX announced a major leadership transition on January 5, 2026, as founder Tim Van Hauwermeiren steps down from his CEO position after steering the company through remarkable growth. This Argenx…
Read More...
Read More...
